Viewing Study NCT06383195



Ignite Creation Date: 2024-05-06 @ 8:26 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06383195
Status: RECRUITING
Last Update Posted: 2024-04-25
First Post: 2024-04-17

Brief Title: The Reliability and Validity of the Ankylosing Spondylitis Performance Index ASPI in Enthesitis-Related Arthritis
Sponsor: Hacettepe University
Organization: Hacettepe University

Study Overview

Official Title: The Reliability and Validity of the Ankylosing Spondylitis Performance Index ASPI Physical Function Test in Enthesitis-Related Arthritis
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study assesses the test-retest reliability construct validity and minimal detectable change of the Ankylosing Spondylitis Performance Index ASPI in assessing the physical function of patients with Enthesitis-related arthritis ERA
Detailed Description: Enthesitis-related arthritis ERA which is considered the counterpart of adult spondyloarthropathies is a human leukocyte antigen HLA B27-related subtype of juvenile idiopathic arthritis JIA characterized by enthesitis and arthritis which can also affect the sacroiliac joints and axial spine Compared to other JIA categories ERA patients tend to have higher pain intensity lower physical functionality and poorer health status Maintaining or improving physical functionality is one of the primary treatment goals for ERA patients Physical functionality is also considered an important outcome measure for assessing disease course and effectiveness of treatment When the literature is examined it is seen that self-report-based questionnaires are used more frequently and performance-based measurements are used less in the evaluation of ERA patients

The Ankylosing Spondylitis Performance Index ASPI is a physical performance test that consists of a combination of three reliable tests bending putting on socks and standing up from the floor developed from the Bath Ankylosing Spondylitis Functional Index BASFI It is reported that applying ASPI can provide more objective information about the improvement in physical functionality and a better estimate of the patients abilities

ASPI has significant potential in this disease group considering factors such as the fact that it was developed in adult spondyloarthropathy patients which is the equivalent of ERA However its psychometric properties must be appropriate for the ASPI to be used in clinical settings and research To our knowledge no studies have been conducted in the current literature on the validity and reliability of the ASPI in ERA patients Therefore this study aimed to evaluate the test-retest reliability construct validity and minimal detectable change of the ASPI in assessing the physical function of patients with ERA

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None